Skip to content

Effect of oliceridine combined with ciprofol on respiratory events during hysteroscopic surgery

Effect of oliceridine combined with ciprofol on respiratory events during hysteroscopic surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087284
Enrollment
Unknown
Registered
2024-07-24
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Interventions

Fentanyl :Fentanyl

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-60 years, 2.ASA I-III, 3.Patients undergoing hysteroscopy under non-intubation general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with difficult airway; 2. Patients allergic to the study drug; 3. Patients with severe hypertension (systolic blood pressure >= 180mmHg, or diastolic blood pressure >= 110mmHg); 4. Patients with severe arrhythmia; 5. Patients with liver and kidney dysfunction; 6. Patients with a history of psychotropic drug use; 7. Patients with communication difficulties; 8. Patients with severe anemia, shock, metabolic diseases, electrolyte disorders; 9. Patients with gastric retention or delayed gastric emptying.

Design outcomes

Primary

MeasureTime frame
Incidence of respiratory events during anesthesia;

Secondary

MeasureTime frame
Vital signs(blood pressure, HR, SpO2, RR, BIS);dose of vasoactive drugs;dose of anesthesia;Time of surgery and anesthesia;VAS pain score before leaving PACU;Patient comfort level;Operator comfort level;Controllability evaluation of depth of anesthesia;

Countries

China

Contacts

Public ContactXuehai Guan

The First Affiliated Hospital of Guangxi Medical University

guan_xh@aliyun.com+86 185 8769 7310

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026